Progressive multifocal leukoencephalopathy: a complication of prolonged immunosuppression for plasma cell myeloma.

Szczegóły

Tytuł:: Progressive multifocal leukoencephalopathy: a complication of prolonged immunosuppression for plasma cell myeloma.
Autorzy:: Burn SC; Central Adelaide Local Health Network, Adelaide, SA.
Kalro A; Central Adelaide Local Health Network, Adelaide, SA.
Źródło:: The Medical journal of Australia [Med J Aust] 2021 Nov 15; Vol. 215 (10), pp. 454-455. Date of Electronic Publication: 2021 Oct 22.
Typ publikacji:: Case Reports; Journal Article
Język:: English
Imprint Name(s):: Publication: : Pyrmont, NSW : Australasian Medical Publishing Co.
Original Publication: Sydney : Australasian Medical Pub. Co.
MeSH Terms:: Immunocompromised Host*
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Immunosuppressive Agents/*adverse effects
Leukoencephalopathy, Progressive Multifocal/*diagnostic imaging
Leukoencephalopathy, Progressive Multifocal/*immunology
Multiple Myeloma/*drug therapy
Stem Cell Transplantation/*adverse effects
Aged ; Humans ; Leukoencephalopathy, Progressive Multifocal/etiology ; Magnetic Resonance Imaging ; Male ; Transplantation, Autologous
References:: Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology 2013; 80: 1430-1438.
Pavlovic D, Patera AC, Nyberg F, et al. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Therap Adv Neurol Disord 2015; 8: 255-273.
Bennett KM, Storrar N, Johnson P, Fernandes PM. Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma. Clin Case Rep 2020; 8: 938-943.
Akiyama M, Takahashi T, Nomura S, et al. Progressive multifocal leukoencephalopathy in patient with multiple myeloma. Int J Hematol 2010; 92: 186.
Cortese, I, Muranski P, Enose-Akahata Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 2019; 380: 1597-1605.
Contributed Indexing:: Keywords: Central nervous system viral diseases; Cord blood stem cell transplantation; Hemic and immune systems; Immunosuppression; Immunotherapies; Myeloma; Stem cells
Substance Nomenclature:: 0 (Immunosuppressive Agents)
Entry Date(s):: Date Created: 20211023 Date Completed: 20211122 Latest Revision: 20211122
Update Code:: 20240105
DOI:: 10.5694/mja2.51315
PMID:: 34687047
: Czasopismo naukowe

Full Text Finder

Informacja